Katten Muchin Rosenman LLP

An appellate court decision last week ruled that companies can patent genes, reversing a controversial lower court ruling that questioned the validity of about 4,000 human genes. “Viewing the decision as a whole, diagnostic claims remain patentable so long as they do not exclusively recite mental steps, such as ‘comparing’ or ‘analyzing’ sequence information,” says Sarah Rous

As oral arguments in the Roger Clemens perjury trial begin today, the case is likely to turn on the testimony of star witness Brian McNamee.

The SEC’s recently-adopted rules to implement the whistleblower program as required by the Dodd-Frank Act will go into effect on August 12, fueling concern by companies that tipsters will circumvent internal reporting channels in favor of submitting complaints directly to the SEC.